	A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology Cevallos-Cueva M, Onejeme C, Ghanem L, Fonseca LO, Tyring SK. PMID: 41774413 [PubMed - as supplied by publisher]
	Psychiatric and Psychological Approach in Patients with Atopic Dermatitis, Hidradenitis Suppurativa and Psoriasis: A Propensity-Matched Real-World Cohort Study. Dermatol Ther (Heidelb) Szepietowska M, Krajewski PK, Pacan P, Wojas-Pelc A, Szepietowski JC, Jaworek AK. PMID: 41774407 [PubMed - as supplied by publisher]
	Exploring clinical subtypes of Chinese patients with psoriatic arthritis based on cluster analysis: a national registry study (CREPARÂ V). Clin Rheumatol Zhao Y, Li H, Duan X, Wu L, Wang Y, Liang X, Qiao L, Jiang N, Huang C, Zeng X, Leng X. PMID: 41774297 [PubMed - as supplied by publisher]
	Clinical assessment of Psoriatic Arthritis. Best Pract Res Clin Rheumatol Kimpton J, Tillett W. PMID: 41771717 [PubMed - as supplied by publisher]
	Regulatory roles of microRNAs in epigenetic and immune gene networks in psoriasis. Gene Singh H, Jha H, Taliyan R. PMID: 41771325 [PubMed - as supplied by publisher]
	The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study. Dermatol Ther (Heidelb) Alexis A, McMichael A, Vashi N, Bhutani T, Yeung J, Alkousakis T, Rowland K, Choi O, Ma T, Chan D, Lester J, Rodriguez AO, Yadav G, Kindred C, Grimes P, Taylor SC, Desai SR. PMID: 41770445 [PubMed - as supplied by publisher]
	Real-world outcomes of deucravacitinib in Chinese plaque psoriasis patients: a 24-week prospective study. J Dermatolog Treat Zhang Z, Tan X, Wu Z, Zhou J. PMID: 41769731 [PubMed - in process]
	Preferences of Chinese Dermatologists for Large Language Model Responses in Clinical Psoriasis Scenarios: A Nationwide Cross-Sectional Survey in China. Health Care Sci Yang J, Xu J, Song X, Li C, Chen L, Bi L, Jiang T, Zuo X, Cui Y. PMID: 41767170 [PubMed]
	From static pathology to dynamic immunity: immunological plasticity and histopathological remodeling in atopic dermatitis and psoriasis. Front Immunol Shen W, Yao Y, Ma YM, Xie XL, Tang SL, Wu Y, Zhong HJ, Li YM, Sun H. PMID: 41766873 [PubMed - in process]
	The dual potential of topical roflumilast: advancing psoriasis therapy and pioneering oral mucosal disease treatment. Immunopharmacol Immunotoxicol Sun J, Shi F, Li L. PMID: 41766373 [PubMed - as supplied by publisher]
	Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin. Ann Rheum Dis Boix-Amorós A, Bu K, Blank RB, Cantor A, Gutiérrez-Casbas A, Rodríguez-Lago I, Marin-Jimenez I, Sanz J, Masmitja JG, Trujillo E, Muñoz MC, Vivar MLG, Carrillo M, Hernández MVH, Calvet X, Salaet MA, Romero MI, García AB, Pérez S, Llorente JFG, Gonzalez-Lama Y, Argumánez CM, Plaza Z, Domínguez M, Cañete JD, Diaz-Gonzalez JF, Scher JU, Clemente JC. PMID: 41763967 [PubMed - as supplied by publisher]
	Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility. Curr Opin Immunol Kang JH, Coates LC. PMID: 41763171 [PubMed - as supplied by publisher]
	Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care. Adv Ther Dege T, Steffens O, Kiesel Ö, Bychkova I, Leichtfuss L, Schulze-Hagen T, Goebeler M, Schmalzing M, Leipe J, Olsavszky V, Strunz PP, Glatzel C, Schmieder A. PMID: 41762372 [PubMed - as supplied by publisher]
	Unravelling Fibromyalgia in Psoriatic Arthritis. Rheumatol Ther Findeisen KE, Guymer EK, Littlejohn GO. PMID: 41758473 [PubMed - as supplied by publisher]
	Biological Treatment of Psoriasis-Data So Far. Pharmaceuticals (Basel) Matwiejuk M, Mik, My, Chabowski A, Flisiak I. PMID: 41754879 [PubMed]
	The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum. Medicina (Kaunas) Gupta AK, Bamimore MA, Wang T, Bhutani T, Piguet V, Talukder M. PMID: 41752798 [PubMed - in process]
	Increased Risk of Incident Uveitis Among Patients with Psoriasis: A Nationwide Population-Based Cohort Study. Diagnostics (Basel) Ehrenberg S, Elizur Y, Ben-Shabat N, David P, Sharif K, Bernstein YS, Abu Hilwe I, Cohen AD, Watad A, Amital H, Patt YS. PMID: 41750775 [PubMed]
	Impact of deucravacitinib on NLR and other inflammatory biomarkers of cardiovascular risk in psoriasis: post hoc analyses of phase 3 trials. J Invest Dermatol Luo Y, Bal AB, Balagula Y, Garshick M, Mehta NN. PMID: 41747955 [PubMed - as supplied by publisher]
	Ambient air pollution and psoriasis: a nationwide cross-sectional study of 149â€‰744 Chinese patients in 31 provinces. J Glob Health Bi L, Wang Z, Yang J, Tian Z, Zhao H, Xu Z, Chen K, Zhuang Z, Huang X, Ouyang H, Sheng Y, Cui Y. PMID: 41747084 [PubMed - in process]
	Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study. RMD Open Schuster L, Temiz A, Mutlu MY, Tascilar K, Bayat S, Corte G, Rech J, Hueber A, Liphardt AM, Kleyer A, Simon D, Roemer F, Schett G, Fagni F. PMID: 41741168 [PubMed - in process]

Articles 1 - 20 / 27519

Page 1 of 1376



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy